lamtreatmentalliance.org/summit_2007_stockholm.html -
[Cached Version]
Published on: 9/11/2008
Last Visited: 9/11/2008
Brendan Manning
...
Brendan Manning, PhDHarvard School of Public Health USA
Dr. Brendan Manning completed his doctoral training at Yale University in 2000 and joined the laboratory of Dr. Lewis Cantley at Harvard Medical School as a postdoctoral fellow.
...
In 2004, Dr. Manning joined the faculty of the Department of Genetics and Complex Diseases at the Harvard School of Public Health.His laboratory uses a combination of biochemistry, cell biology, and mouse genetics to study signaling pathways involving the TSC proteins.This research is aimed at identifying the underlying defects contributing to tumor formation and physiology in TSC and LAM patients and uncovering potential targets for therapeutic intervention.